汇添富纳斯达克生物科技ETF持股明细
| 股票名称 |
股票代码 |
股票数量（股） |
股票币值（元） |
占资产净值比例 |
| 再生元制药 |
REGN |
15569.0 |
106318623.32 |
8.03% |
| 福泰制药 |
VRTX |
35754.0 |
106038532.09 |
8.01% |
| Alnylam Pharmaceuticals Inc |
ALNY |
24174.0 |
25632846.51 |
1.94% |
| 安进 |
AMGN |
54977.0 |
110902375.24 |
8.38% |
| 吉利德科学 |
GILD |
208809.0 |
108519864.38 |
8.2% |
| 生化基因 |
BIIB |
27949.0 |
42759031.16 |
3.23% |
| 拜玛林制药 |
BMRN |
36248.0 |
22462062.77 |
1.7% |
| 阿斯利康(US ADR) |
AZN |
111897.0 |
53787349.32 |
4.06% |
| Illumina Inc |
ILMN |
30561.0 |
29775136.11 |
2.25% |
| Moderna Inc |
MRNA |
73431.0 |
55517008.22 |
4.19% |
| Moderna Inc |
MRNA |
44100.0 |
31062916.11 |
3.89% |
| 生化基因 |
BIIB |
16761.0 |
30719397.87 |
3.85% |
| Alnylam Pharmaceuticals Inc |
ALNY |
14512.0 |
19673912.7 |
2.47% |
| 再生元制药 |
REGN |
10083.0 |
62722960.99 |
7.86% |
| 吉利德科学 |
GILD |
108461.0 |
62231616.67 |
7.8% |
| Illumina Inc |
ILMN |
18368.0 |
18114432.48 |
2.27% |
| 阿斯利康(US ADR) |
AZN |
64318.0 |
30680962.39 |
3.85% |
| 安进 |
AMGN |
30813.0 |
62857264.49 |
7.88% |
| 拜玛林制药 |
BMRN |
21783.0 |
14875914.22 |
1.87% |
| 福泰制药 |
VRTX |
23420.0 |
67493624.99 |
8.46% |
| 阿斯利康(US ADR) |
AZN |
14955.0 |
7271361.12 |
3.98% |
| Alnylam Pharmaceuticals Inc |
ALNY |
3205.0 |
4075293.97 |
2.23% |
| 福泰制药 |
VRTX |
6053.0 |
15112547.21 |
8.27% |
| 吉利德科学 |
GILD |
27596.0 |
14848144.03 |
8.12% |
| 生化基因 |
BIIB |
3723.0 |
6869978.92 |
3.76% |
| Seagen Inc |
SGEN |
4821.0 |
7343321.02 |
4.02% |
| 再生元制药 |
REGN |
2549.0 |
15061246.24 |
8.24% |
| Moderna Inc |
MRNA |
9769.0 |
7244705.46 |
3.96% |
| 安进 |
AMGN |
8224.0 |
15869384.43 |
8.68% |
| Horizon Therapeutics plc |
HZNP |
5880.0 |
4884110.64 |
2.67% |
| 福泰制药 |
VRTX |
3371.0 |
8571884.24 |
8.53% |
| 阿斯利康(US ADR) |
AZN |
7646.0 |
3954132.77 |
3.93% |
| 安进 |
AMGN |
5065.0 |
8125638.27 |
8.08% |
| Seagen Inc |
SGEN |
2457.0 |
3416894.54 |
3.4% |
| 吉利德科学 |
GILD |
14526.0 |
8089419.09 |
8.05% |
| 生化基因 |
BIIB |
1885.0 |
3879837.31 |
3.86% |
| 再生元制药 |
REGN |
1412.0 |
7331141.18 |
7.29% |
| BELLUS Health Inc |
BLU |
1634.0 |
174034.55 |
0.17% |
| Alnylam Pharmaceuticals Inc |
ALNY |
1633.0 |
2241240.98 |
2.23% |
| Illumina Inc |
ILMN |
2072.0 |
2807073.58 |
2.79% |
| Moderna Inc |
MRNA |
4990.0 |
4380894.15 |
4.36% |
| 生化基因 |
BIIB |
1958.0 |
3740834.87 |
3.75% |
| Illumina Inc |
ILMN |
2140.0 |
3419749.61 |
3.43% |
| 吉利德科学 |
GILD |
14146.0 |
8065270.45 |
8.09% |
| Horizon Therapeutics plc |
HZNP |
3094.0 |
2320429.88 |
2.33% |
| 再生元制药 |
REGN |
1456.0 |
8220968.74 |
8.24% |
| 安进 |
AMGN |
4918.0 |
8169946.23 |
8.19% |
| 福泰制药 |
VRTX |
3483.0 |
7540926.69 |
7.56% |
| Moderna Inc |
MRNA |
5235.0 |
5524787.02 |
5.54% |
| 阿斯利康(US ADR) |
AZN |
8169.0 |
3896324.61 |
3.91% |
| Seagen Inc |
SGEN |
2531.0 |
3521413.45 |
3.53% |
| 福泰制药 |
VRTX |
2607.0 |
5243295.35 |
6.96% |
| Moderna Inc |
MRNA |
3901.0 |
4880078.64 |
6.48% |
| 阿斯利康(US ADR) |
AZN |
6207.0 |
2930944.66 |
3.89% |
| 安进 |
AMGN |
3094.0 |
5659490.79 |
7.51% |
| 生化基因 |
BIIB |
1452.0 |
2800380.97 |
3.72% |
| 吉利德科学 |
GILD |
10089.0 |
6032323.17 |
8.01% |
| 再生元制药 |
REGN |
1088.0 |
5467079.51 |
7.26% |
| Illumina Inc |
ILMN |
1598.0 |
2250370.91 |
2.99% |
| Alnylam Pharmaceuticals Inc |
ALNY |
1250.0 |
2068921.49 |
2.75% |
| Horizon Therapeutics plc |
HZNP |
2302.0 |
1824499.55 |
2.42% |
| 福泰制药 |
VRTX |
4441.0 |
8899453.27 |
3.19% |
| 吉利德科学 |
GILD |
20078.0 |
8812682.5 |
3.16% |
| Alnylam Pharmaceuticals Inc |
ALNY |
2107.0 |
3131218.22 |
1.12% |
| 再生元制药 |
REGN |
1877.0 |
7835348.01 |
2.81% |
| Moderna Inc |
MRNA |
6907.0 |
6710957.97 |
2.4% |
| 安进 |
AMGN |
5072.0 |
8540277.32 |
3.06% |
| 阿斯利康(US ADR) |
AZN |
9793.0 |
4490710.91 |
1.61% |
| Illumina Inc |
ILMN |
2719.0 |
3626647.02 |
1.3% |
| Seagen Inc |
SGEN |
3211.0 |
3643014.13 |
1.31% |
| 生化基因 |
BIIB |
2554.0 |
3617670.66 |
1.3% |
